Delivery Order SPE2DB25D3001-SPE2DB25FQUJS
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,827.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of RINVOQ ER 15 MG TABLET, a medication used to treat certain medical conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The contract is not set aside and is open to full and open competition....
This federal contract award, valued at $6,223.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed-price delivery order contract type, is for the delivery of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $7,385.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of the medication RINVOQ ER 15 MG TABLET UU 30S, a prescription drug used to treat certain medical conditions. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award is a delivery order with a firm fixed price valued at $9,834.22, awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S, with a completion date of June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,995.81, is a delivery order for the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has a firm fixed price pricing type and a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award, valued at $26,492.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a medication, and has a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,962.91 firm fixed-price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $33,357.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of the prescription medication RINVOQ ER 45 MG TABLET, which is used to treat various medical conditions. The contract is a firm fixed-price arrangement with an ultimate completion date of April 11, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,335.54 firm fixed-price contract provides for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a prescription medication, with a completion date of February 14, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $30,151.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a completion date of January 27, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating it was an open competition. Amerisourcebergen Drug Corp holds a...